Bristol-Myers Squibb (BMY) Revenue — Quarter Ended Mar 31, 2026
Revenue increased year-over-year but declined from the immediately preceding quarter. The sequential decline contrasts with the prior quarter's level.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue increased year-over-year but declined from the immediately preceding quarter. The sequential decline contrasts with the prior quarter's level.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.5B
Revenue reported for this quarter.
Quarter-over-quarter
-8.1%
Change from the immediately preceding quarter.
Year-over-year
+2.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$48.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $12.3B | +0.6% |
| Sep 30, 2025 | $12.2B | +2.8% |
| Dec 31, 2025 | $12.5B | +1.3% |
| Mar 31, 2026 | $11.5B | +2.6% |
Revenue performance
The reported revenue grew compared with the same quarter one year earlier, but it fell short of the level achieved in the immediately preceding quarter.
Quarterly comparison
Revenue was higher than the same quarter last year, yet lower than the prior quarter's figure.
What to watch
The sequential decline in revenue is a key point to watch.